Table 2. Case-specific clinicopathological parameters and experimental data on the number of investigated lymph nodes and corresponding rt-MSP results (n=49).

Patient	pT category	Grading	MSI+	Recurrence	Number of investigated lymph nodes	rt-MSP
1	3	2	Yes	No	11	−
2	3	2	No	No	18	+
3	3	2	No	No	29	+
4	3	2	No	Local	6	+
5	3	2	ND	No	24	−
6	2	2	No	No	5	−
7	3	2	ND	No	7	−
8	3	2	No	Distant	14	−
9	3	2	ND	No	5	−
10	2	1	ND	No	9	−
11	3	2	No	No	5	+
12	2	2	Yes	No	9	−
13	3	2	No	No	4	−
14	2	2	No	No	11	−
15	3	3	No	No	16	−
16	3	2	ND	No	4	−
17	4	2	Yes	No	17	+
18	3	2	ND	No	1	−
19	3	2	ND	No	3	−
20	3	2	No	No	10	−
21	3	2	ND	No	7	−
22	3	2	No	No	9	−
23	2	2	Yes	Distant	4	−
24	3	2	ND	No	2	−
25	2	2	ND	No	2	−
26	3	2	No	No	5	+
27	3	2	ND	No	4	−
28	2	2	Yes	No	19	+
29	3	2	ND	No	7	−
30	3	2	ND	No	4	+
31	3	1	Yes	Local and distant	7	+
32	3	2	ND	No	5	−
33	3	2	No	No	5	+
34	3	3	No	No	7	+
35	2	2	No	No	10	+
36	3	2	Yes	No	17	−
37	3	2	No	No	14	−
38	3	1	No	No	6	+
39	3	2	ND	No	21	−
40	3	2	ND	No	12	−
41	3	2	ND	No	18	−
42	3	2	No	No	6	−
43	2	3	ND	No	13	−
44	2	2	No	No	9	+
45	3	2	ND	No	5	−
46	2	2	ND	No	16	−
47	2	2	ND	No	22	−
48	3	2	ND	No	14	−
49	3	2	No	No	9	+

MSI+=microsatellite instability; ND=not determined; rt-MSP=real-time methylation-specific PCR.